LeonaBio LONA
NASDAQ LONA
$4.02 -0.45 (-10.07%)
At close: Nov 10, 2026 · 4:00 PM EST

LeonaBio (LONA) Convertible Debt (2019)

Updated

LeonaBio's Convertible Debt came in at $1.55 million for Q4 2019.

Analysis

LeonaBio (LONA) Convertible Debt (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 LeonaBio 106.60 Mn -125.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 1.55 Mn
API Access

LeonaBio Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=LONA&period=max&api_key=YOUR_API_KEY